
Johnson & Johnson, ViaCyte testing possible diabetes cure
Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder.
Feb 4, 2016
0
89